FDA Peptide Update: Category 2 Removals Explained Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea